OBM Hepatology and Gastroenterology Editorial Office

2000 Auburn Drive, One Chagrin Highlands

Suite 200, Beachwood, OH 44122

USA

Tel.:  +1-216-370-7293

Fax:  +1-216-378-7505

E-Mail: [email protected]


Current Issue 2018  Archive 2017 
Biography
Biography

Editor-in-Chief of OBM Hepatology and Gastroenterology

Osamu Yokosuka is an Emeritus Professor of Chiba University, Japan. He graduated from Chiba University School of Medicine in 1975 then worked as a trainee under Professor K. Okuda in Chiba University Hospital till 1978. Dr. Yokosuka was a research fellow worked under Professor S. Scherlock and Professor B. H. Billing in Royal Free Hospital, London, UK from 1978 to 1980; under Professor M. Omata in Chiba University from 1980 to 1985; and under Dr. J Summers in Fox Chase Cancer Center, PA, USA in 1984. In 1985, he received a Degree of Doctor of Medical Science, and served as an Assistant Professor in Chiba University till 1994, then as Lecturer in Medicine till 2006 when he was appointed as Director and Professor of Medicine. From 2013 to 2015, he served as the Dean of Chiba University School of Medicine.

Dr. Yokosuka was the Secretary General of APASL (2008-2014). In 2016, he was elected as the President of APASL Tokyo, the President of 52nd Annual Meeting of Japan Society of Hepatology, and the President of Funabashi Central Hospital. Dr. Yokosuka’s research mainly focuses on Hepatitis and Hepatocellular Carcinoma. So far, he has published more than 700 original papers.

Biography

The Associate Editor of OBM Hepatology and Gastroenterology

Tatsuo Kanda received a medical degree in 1991 at Niigata University School of Medicine, Japan, and his PhD in 1999 at Chiba University Graduate School of Medicine, Japan. He had post-doctor training for 3 years under Prof. Ratna Ray and Prof. Ranjit Ray at Saint Louis University, St. Louis, MO, USA. In Dec. 2008, Tatsuo Kanda became a Tenure-track Associate Professor at Department of Medicine and Clinical Oncology, Chiba University, Graduate School of Medicine, Japan. In Feb. 2013, Tatsuo Kanda was nominated a permanent Associate Professor at Department of Gastroenterology and Nephrology, Chiba University, Graduate School of Medicine, Japan. In 2017, Tatsuo Kanda became an Associate Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nihon University School of Medicine. For ~25 years, he has focused his scientific interests on the topics related to liver diseases including acute liver failure, viral hepatitis and autoimmune liver diseases, and worked with Prof. Osamu Yokosuka. Tatsuo Kanda is also an expert for hepatitis A virus (HAV), HBV and HCV, and translation and replication of these viruses, and hepatocarcinogenesis. With his expertise in antiviral therapies and hepatitis virus research, Tatsuo Kanda also sees a lot of patients in clinical daily practice. Tatsuo Kanda has published more than 200 articles in peer-reviewed Journal.

Special Issue

Pathology and Management of Cirrhosis

Submission Deadline: January 31, 2019 (Open)               Submit Now

Guest Editor

Tatsuo Kanda, MD, PhD
Associate Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nihon University School of Medicine, 30-1 Oyaguchi-Kamicho, Itabashi-ku, Tokyo 173-8610, Japan
E-Mails: [email protected]; [email protected]
Website: https://www.researchgate.net/profile/Tatsuo_Kanda2
Research Interests: hepatology; gastroenterology; infectious diseases; viral hepatitis

About This Topic

In general, cirrhosis seems to be irreversible condition and progress to end-stage liver diseases. Hepatocellular carcinoma often occurs in cirrhosis of the liver. It is still unknown whether it is different reversibility between compensated and decompensated cirrhosis although direct-acting antivirals against hepatitis C virus have appeared. In recent, treatment for cirrhosis other than transplant has also been developing. In this special issue of OBM Hepatology and Gastroenterology, we welcome any manuscripts concerning all aspect of liver cirrhosis such as pathology, treatment as well as hepatocellular carcinoma.

Planned Papers

Title:Platelets in liver cirrhosis
Author:Paola Romecín, Ana I. García-Guillén, Joaquín García-Estañ *, Noemí M. Atucha
Affiliation:Depto. Fisiología, Fac. Medicina, 30120 Murcia, Spain
Keywords :Cholestasis; Calcium; Thrombin; Liver cirrhosis; Nitric oxide; Oxidative stress

Title:Optimising Surveillance Strategy in Patients with Cirrhosis
Author:Shariff Mohamed
Affiliation:
1. Consultant in Gastroenterology & Hepatology; West Hertfordshire Hospitals NHS Trust
2. Gastroenterology Department, Watford General Hospital, Watford

Title:NASH and HCC
Authors: Behnam Saberi; Soohwan Chun, Aryana Chan, Douglas Dieterich
Affiliation: Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Title: Surgical strategies for centrally located hepatocellular carcinoma.
Author: Emilio De Raffele et al.
Affiliation: Dipartimento dell’ Apparato Digerente, Azienda Ospedaliero-Universitaria di Bologna, Policlinico S.Orsola-Malpighi, Bologna, Italy

Title: Long-term complications of radio-frequency thermal ablation of hepatocellular carcinoma. A case Report.
Author: Emilio De Raffele et al.
Affiliation: Dipartimento dell’ Apparato Digerente, Azienda Ospedaliero-Universitaria di Bologna, Policlinico S.Orsola-Malpighi, Bologna, Italy

Title:The Rational Use of Diuretics in the Management of Cirrhotic Ascites
Authors: Masaaki Takamura, Shuji Terai
Affiliation: Division of Gastroenterology and Hepatology, Graduate School of Medical and Denithtal Science, Niigata University, Niigata, Japan